Stoke Therapeutics Inc.

NASDAQ: STOK · Real-Time Price · USD
17.99
0.82 (4.78%)
At close: Aug 15, 2025, 2:42 PM

Stoke Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
52.48M 50.27M -88.98M -105.46M -103.57M -108.53M -104.7M -103.4M -104.97M -98.96M -101.07M -99.86M -96.35M -93.66M -85.81M -75.92M -67M -58M
Depreciation & Amortization
1.99M 2.09M 2.18M 2.27M 2.37M 2.44M 2.47M 2.45M 2.21M 1.9M 1.55M 1.17M 1.04M 985K 974K 976K 956K 931K
Stock-Based Compensation
28.98M 28.91M 27.67M 26.59M 25.75M 24.98M 25.36M 25.09M 24.36M 23.77M 22.85M 21.75M 20.44M 18.73M 16.45M 13.34M 10.52M 7.71M
Other Working Capital
-24.85M -21.58M -31.23M -8.6M -8.47M 634K -2.82M -5.97M -4.95M -13.29M 47.69M 50.5M 54.52M 58.48M 2.65M -937K -3.08M -3.02M
Other Non-Cash Items
1.56M 102K 423K 1.13M 1.44M 1.83M 1.98M 1.87M 1.96M 1.75M 1.78M 1.77M 1.66M 1.6M 1.26M 1.14M 1.08M 1.06M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 57K 106K 143K 172K 115K 66K 29K
Change in Working Capital
-23.42M -11.84M -28.14M -8.84M -5.95M -4.84M -6.03M -8.66M -11.01M -14.16M 43.02M 49.36M 54.73M 57.93M 46K -1.23M -3.38M -3.32M
Operating Cash Flow
61.6M 69.54M -86.85M -84.31M -79.95M -84.28M -81.07M -82.79M -87.58M -85.71M -31.87M -25.75M -18.38M -14.28M -66.91M -61.58M -57.77M -51.59M
Capital Expenditures
-451K -343K -203K -390K -670K -1.46M -1.62M -1.8M -3.44M -3.29M -3.96M -3.76M -2M -1.84M -1.2M -1.09M -1.08M -644K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -45.34M -114.64M -69.29M -69.29M 46.49M 115.78M 70.44M 70.44M n/a n/a n/a
Purchase of Investments
-279.61M -186.29M -167.27M -138.13M -88.23M n/a n/a 4.87M -4.84M -57.38M -201.32M -288.43M -283.71M -313.4M -169.46M -87.23M -82.23M n/a
Sales Maturities Of Investments
116.03M 82.8M 60M 45M 40M 64.31M 107.56M 110.59M 174.59M 203.65M 159.4M 153.37M 74.37M 21M 12M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a 24.31M 77.56M 122.91M 192.2M 122.54M -65.65M -99.19M -173.48M -210.37M -75.43M -87.23M -82.23M n/a
Investing Cash Flow
-164.03M -103.83M -107.47M -93.52M -48.9M 62.85M 105.95M 113.67M 166.31M 142.99M -45.88M -56.58M -129.1M -212M -76.43M -88.31M -83.32M -644K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.62M 1.84M 2.25M 1.69M 1.19M 471K 364K 402K 836K 1.11M 1.06M 1.19M 1.17M 1M 1.28M 2.58M 2.85M 3.06M
Financial Cash Flow
10.65M 130.75M 131.09M 137.87M 130.27M 9.67M 53.01M 45.71M 45.58M 48.96M 46.41M 46.54M 46.51M 43.24M 1.28M 107.98M 108.25M 108.46M
Net Cash Flow
-91.78M 96.46M -63.23M -39.96M 1.42M -11.76M 77.89M 76.58M 124.31M 106.23M -31.34M -35.79M -100.97M -183.04M -142.05M -41.91M -32.84M 56.23M
Free Cash Flow
61.15M 69.2M -87.05M -84.7M -80.62M -85.74M -82.68M -84.59M -91.03M -89M -35.83M -29.51M -20.38M -16.12M -68.11M -62.67M -58.85M -52.23M